Tevogen Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
6.89
+0.14 (2.07%)
At close: Aug 28, 2026, 4:00 PM EDT
6.81
-0.08 (-1.16%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Tevogen Market Cap
Tevogen has a market cap or net worth of $44.86 million as of August 28, 2026. Its market cap has decreased by -75.21% in one year.
Market Cap
44.86M
Enterprise Value
53.23M
1-Year Change
-75.21%
Ranking
Category
Stock Price
$6.89
ChartMarket Cap Chart
Since January 5, 2022, Tevogen's market cap has decreased from $446.69M to $44.86M, a decrease of -89.96%. That is a compound annual growth rate of -39.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 44.86M | -31.80% |
| Dec 31, 2025 | 65.79M | -63.51% |
| Dec 31, 2024 | 180.30M | 2.42% |
| Dec 29, 2023 | 176.04M | -64.45% |
| Dec 30, 2022 | 495.15M | 10.85% |
| Jan 5, 2022 | 446.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veru Inc. | 47.40M |
| Metagenomi Therapeutics | 45.90M |
| Werewolf Therapeutics | 45.68M |
| Grace Therapeutics | 45.54M |
| Filana Therapeutics | 45.28M |
| Karyopharm Therapeutics | 45.14M |
| Mereo BioPharma Group | 44.02M |
| Aligos Therapeutics | 43.71M |